Cargando…

Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer

SIMPLE SUMMARY: Gastroesophageal cancer is a devastating disease with dismal survival even in localized settings. Novel therapeutic regimen are underway to improve patient management and outcome. This review aims to demonstrate the advances of immunotherapy and targeted therapies in treatment of loc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puhr, Hannah Christina, Reiter, Thorsten J., Preusser, Matthias, Prager, Gerald W., Ilhan-Mutlu, Aysegül
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047169/ https://www.ncbi.nlm.nih.gov/pubmed/36980786 http://dx.doi.org/10.3390/cancers15061900

Ejemplares similares

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma
por: Puhr, Hannah C., et al.
Publicado: (2023)

Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?
por: Puhr, Hannah Christina, et al.
Publicado: (2021)

Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis
por: Puhr, H. C., et al.
Publicado: (2019)

Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis
por: Puhr, Hannah C., et al.
Publicado: (2021)

PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
por: Beer, Andrea, et al.
Publicado: (2020)

New emerging targets in cancer immunotherapy: the role of LAG3
por: Puhr, Hannah Christina, et al.
Publicado: (2019)

Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy
por: Puhr, Hannah C., et al.
Publicado: (2022)

How we treat esophageal squamous cell carcinoma
por: Puhr, H.C., et al.
Publicado: (2023)

Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)
por: Puhr, H.C., et al.
Publicado: (2022)

Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy
por: Jomrich, Gerd, et al.
Publicado: (2021)

NephroCheck data compared to serum creatinine in various clinical settings
por: Pajenda, Sahra, et al.
Publicado: (2015)

Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
por: Mair, Maximilian J, et al.
Publicado: (2020)

Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
por: Marhold, Maximilian, et al.
Publicado: (2020)

MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2018)

Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction
por: Feka, Joy, et al.
Publicado: (2023)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
por: Ratosa, Ivica, et al.
Publicado: (2015)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
por: Paireder, Matthias, et al.
Publicado: (2020)

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
por: Mair, Maximilian J., et al.
Publicado: (2023)

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma
por: Koch, Christine, et al.
Publicado: (2019)

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients
por: Unseld, Matthias, et al.
Publicado: (2020)

Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension
por: Winter, Max-Paul, et al.
Publicado: (2020)

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
por: Kieler, Markus, et al.
Publicado: (2020)

Therapeutic Advances in the Treatment of Gastroesophageal Cancers
por: Li, Jenny J., et al.
Publicado: (2023)

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
por: Taghizadeh, Hossein, et al.
Publicado: (2023)

Screening for post‐traumatic stress disorders in 1017 cancer patients and correlation with anxiety, depression, and distress
por: Unseld, Matthias, et al.
Publicado: (2019)

Gastroesophageal reflux disease: recent innovations in endoscopic assessment and treatment
por: Chen, Sheng, et al.
Publicado: (2021)

(Neo)Adjuvant Treatment of Locally Advanced Esophageal and Gastroesophageal Adenocarcinoma: Special Focus on Sex Differences
por: Zander, Thomas, et al.
Publicado: (2022)

Schizophrenia and gastroesophageal reflux symptoms
por: Kasap, Elmas, et al.
Publicado: (2015)

Clinical risk factors for ascites in metastatic pancreatic cancer
por: Berger, J.M., et al.
Publicado: (2023)

Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
por: Maeda, Osamu, et al.
Publicado: (2019)

Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care
por: Sehdev, Amikar, et al.
Publicado: (2013)

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
por: Bartsch, Rupert, et al.
Publicado: (2022)

Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort: THE for locally advanced GEJC
por: Meillat, Hélène, et al.
Publicado: (2022)

Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times
por: Berghoff, Anna Sophie, et al.
Publicado: (2013)

Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
por: Kieler, Markus, et al.
Publicado: (2019)

The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1lc7h098249fs021aebdeun28a